Bull
$5.42
Scenario price
$1.610
+0.010 (+0.63%)At close
Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets.
Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment

Clarivate Completes Sale of Life Sciences & Healthcare Segment for $600 Million

Clarivate Completes Cash Tender Offer for Senior Secured Notes

Clarivate Completes Cash Tender Offer for Senior Secured Notes
Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. It operates in the Industrials sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).
Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.